FRONTLINE TREATMENT WITH THE COMBINATION OBINUTUZUMAB ± CHLORAMBUCIL FOR CHRONIC LYMPHOCYTIC LEUKEMIA OUTSIDE CLINICAL TRIALS: RESULTS OF A MULTINATIONAL, MULTICENTER STUDY BY ERIC AND THE ISRAELI CLL STUDY GROUP

Yair Herishanu; Adir Shaulov; Riva Fineman; Sandra Bašić‐Kinda; Ariel Aviv; Ewa Wasik‐Szczepanek; Ozren Jaksic; Mihnea Zdrenghea; Uri Greenbaum; Inga Mandac; Martin Simkovic; Marta Morawska; Ohad Benjamini; Martin Spacek; Anatoly Nemets; Osnat Bairey; Livio Trentin; Rosa Ruchlemer; Luca Laurenti; Oana Stanca Ciocan; Michael Doubek; Lev Shvidel; Nagib Dali; Fátima Mirás; Anne De Meûter; Maria Dimou; Francesca R. Mauro; Marta Coscia; Horia Bumbea; Róbert Szász; Tamar Tadmor; Odit Gutwein; Massimo Gentile; Lydia Scarfò; Alessandra Tedeschi; Paolo Sportoletti; Eva Gimeno Vázquez; Juan Marquet; Sarit Assouline; Maria Papaioannou; Andrei Braester; Luciano Levato; Michael Gregor; Gian M. Rigolin; Javier Loscertales; Angeles Medina Perez; Marten R. Nijziel; Viola M. Popov; Rosa Collado; Irma Slavutsky; Gilad Itchaki; Shimrit Ringelstein; Neta Goldschmidt; Chava Perry; Shai Levi; Aaron Polliack; Paolo Ghia

AJH_2020_Feb_25._doi/abs/10.1002/ajh.25766